Edition:
United States

Search Results  for '300147.SZ'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Xiangxue Pharmaceutical Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

24 Sep 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Xiangxue Pharmaceutical Co Ltd (300147-SZ)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

27 Sep 2016 Thomson Reuters Stock Report 11 $25.00

Xiangxue Pharmaceutical Co Ltd: Downgraded to Average

27 Sep 2016 Sadif Analytics Prime 3 $10.00

Wright Investors Service Comprehensive Report for Xiangxue Pharmaceutical Co Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

01 Sep 2016 Wright Reports 64 $75.00

Is Xiangxue Pharmaceutical Co Ltd Still a Bargain?

29 Jul 2016 Sadif Analytics Prime 12 $25.00

Thomson Reuters Stock Report - Xiangxue Pharmaceutical Co Ltd (300147-SZ)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 May 2016 Thomson Reuters Stock Report 11 $25.00

Will Xiangxue Pharmaceutical Co Ltd Deliver Long-Term Returns?

29 Apr 2016 Sadif Analytics Prime 12 $25.00

Xiangxue Pharmaceutical Co Ltd: Downgraded to Above Average

15 Mar 2016 Sadif Analytics Prime 3 $10.00

Will Xiangxue Pharmaceutical Co Ltd Bounce Back?

29 Jan 2016 Sadif Analytics Prime 12 $25.00

Xiangxue Pharmaceutical Co Ltd: Upgraded to Good

06 Jan 2016 Sadif Analytics Prime 3 $10.00